At the 1st H trading announcement on 16/1/23, it was said that Synpath for DFU's market entry was expected in 2024 (they didn't say if CY or FY) with a total addressable market of US$400M (so about A$570M). But it will take many years for Synpath to gain traction. The no of people in USA developing DFU's is approx 2M pa (source google search). The current standard of care is antibiotics and or putting the leg in a cast which sounds primitive.
At the 1st H trading announcement on 16/1/23, it was said that...
-
- There are more pages in this discussion • 479 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.45 |
Change
0.010(0.41%) |
Mkt cap ! $1.691B | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.51 | $2.43 | $5.243M | 2.122M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 35541 | $2.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.46 | 2681 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |